Ontrak Health Demonstrates Significant Improvement in Members’ Quality of Life from ReQoL Mental Health Assessment
Ontrak Health (NASDAQ: OTRK) has reported significant improvements in members' quality of life based on data from the Recovering Quality of Life (ReQoL) measure. Key findings include:
- 58% of Medicaid and 29% of Commercial members reported poorer quality of life compared to the general population at baseline
- 35% of Medicaid and 18% of Commercial members showed significant improvements in ReQoL scores after subsequent assessments
These improvements align with positive trends in Depression and Anxiety measures (PHQ-9 and GAD-7) within Ontrak's WholeHealth+ program. The ReQoL tool has proven valuable in uncovering hidden struggles and tracking clinical progress, enhancing the effectiveness of Ontrak's tech-enabled personalized interventions.
Ontrak Health (NASDAQ: OTRK) ha riportato significativi miglioramenti nella qualità della vita dei membri sulla base dei dati provenienti dalla misura Recuperare la Qualità della Vita (ReQoL). I principali risultati includono:
- Il 58% dei membri Medicaid e il 29% dei membri Commerciali hanno segnalato una qualità della vita inferiore rispetto alla popolazione generale all'inizio della valutazione
- Il 35% dei membri Medicaid e il 18% dei membri Commerciali hanno mostrato miglioramenti significativi nei punteggi ReQoL dopo valutazioni successive
Questi miglioramenti sono in linea con le tendenze positive nelle misure di depressione e ansia (PHQ-9 e GAD-7) all'interno del programma WholeHealth+ di Ontrak. Lo strumento ReQoL si è dimostrato utile per scoprire difficoltà nascoste e monitorare i progressi clinici, aumentando l'efficacia degli interventi personalizzati potenziati dalla tecnologia di Ontrak.
Ontrak Health (NASDAQ: OTRK) ha informado mejoras significativas en la calidad de vida de los miembros basadas en datos de la medida Recuperando la Calidad de Vida (ReQoL). Los hallazgos clave incluyen:
- El 58% de los miembros de Medicaid y el 29% de los miembros comerciales reportaron una calidad de vida inferior en comparación con la población general en la línea de base
- El 35% de los miembros de Medicaid y el 18% de los miembros comerciales mostraron mejoras significativas en los puntajes de ReQoL tras evaluaciones posteriores
Estas mejoras se alinean con tendencias positivas en las medidas de depresión y ansiedad (PHQ-9 y GAD-7) dentro del programa WholeHealth+ de Ontrak. La herramienta ReQoL ha demostrado ser valiosa para descubrir luchas ocultas y rastrear el progreso clínico, mejorando la efectividad de las intervenciones personalizadas habilitadas por la tecnología de Ontrak.
온트락 헬스(Ontrak Health) (NASDAQ: OTRK)는 회원들의 삶의 질에서 상당한 개선을 보고했습니다. 이는 회복하는 삶의 질 측정(ReQoL) 데이터에 기반한 것입니다. 주요 발견 사항은 다음과 같습니다:
- 메디케이드(Medicaid) 회원의 58%와 상업적 회원의 29%가 기준선 시점에서 일반 인구와 비교해 더 낮은 삶의 질을 보고했습니다
- 메디케이드 회원의 35%와 상업적 회원의 18%가 후속 평가 후 ReQoL 점수에서 의미 있는 개선을 보였습니다
이러한 개선은 온트락의 WholeHealth+ 프로그램 내에서 우울증과 불안 측정(PHQ-9 및 GAD-7)의 긍정적인 추세와 일치합니다. ReQoL 도구는 숨겨진 어려움을 밝혀내고 임상 진행 상황을 추적하는 데 유용한 것으로 입증되어, 온트락의 기술 기반 개인화된 개입의 효과성을 향상시키고 있습니다.
Ontrak Health (NASDAQ: OTRK) a rapporté d'importantes améliorations de la qualité de vie des membres sur la base des données de la mesure de Récupération de la Qualité de Vie (ReQoL). Les résultats clés incluent :
- 58 % des membres Medicaid et 29 % des membres commerciaux ont signalé une qualité de vie inférieure par rapport à la population générale au départ
- 35 % des membres Medicaid et 18 % des membres commerciaux ont montré des améliorations significatives dans les scores ReQoL après des évaluations ultérieures
Ces améliorations s'alignent sur des tendances positives dans les mesures de dépression et d'anxiété (PHQ-9 et GAD-7) au sein du programme WholeHealth+ d'Ontrak. L'outil ReQoL s'est avéré précieux pour découvrir des luttes cachées et suivre les progrès cliniques, améliorant ainsi l'efficacité des interventions personnalisées optimisées par la technologie d'Ontrak.
Ontrak Health (NASDAQ: OTRK) hat signifikante Verbesserungen der Lebensqualität der Mitglieder berichtet, basierend auf Daten aus der Maßnahme Wiederherstellung der Lebensqualität (ReQoL). Wichtige Ergebnisse sind:
- 58% der Medicaid-Mitglieder und 29% der kommerziellen Mitglieder berichteten zu Beginn von einer schlechteren Lebensqualität im Vergleich zur allgemeinen Bevölkerung
- 35% der Medicaid-Mitglieder und 18% der kommerziellen Mitglieder zeigten nachfolgende signifikante Verbesserungen in den ReQoL-Werten
Diese Verbesserungen stimmen mit positiven Trends in den Maßnahmen zu Depression und Angst (PHQ-9 und GAD-7) innerhalb des WholeHealth+-Programms von Ontrak überein. Das ReQoL-Tool hat sich als wertvoll erwiesen, um verborgene Kämpfe aufzudecken und den klinischen Fortschritt zu verfolgen, was die Effektivität von Ontraks technologiegestützten, personalisierten Interventionen verbessert.
- None.
- None.
The ReQoL assessment, now a standard component of Ontrak's clinical model, has provided valuable insights into factors impacting mental health across diverse populations. ReQoL assessments are intended to evaluate the impact of mental health conditions, psychological interventions, and healthcare interventions on members’ lives because they focus on understanding the person over the diagnosis, consistent with modern recovery-oriented strategies. Integrating this tool in Ontrak's WholeHealth+ program emphasizes the commitment to measurement feedback in continually improving mental health care and outcomes.
Key Findings:
-
Prevalence of Poor Quality of Life: Results from baseline assessments of adults 18 years and older enrolled in the WholeHealth+ program reveal that
58% of the Medicaid population and29% of the Commercial population report a poorer quality of life as compared to the general population. -
Significant Improvements Observed: Ontrak's analysis shows that
35% of Medicaid and18% of Commercial members who completed subsequent assessments have already significantly improved their ReQoL scores (defined as an increase of 5 or more points) in follow-up surveys during the two quarters collected since launch. Ontrak's advanced engagement system and continuous measurement feedback loop ensure that members receive timely, targeted support, contributing to these positive outcomes. This positive trend aligns with the consistently demonstrated improvements in Depression and Anxiety as measured by PHQ-9 and GAD-7, which are also PROMs administered in the Ontrak WholeHealth+ program.
Dr. Judith Feld, MD, MPH, MMM, Chief Medical Officer at Ontrak Health, commented on the findings: "The ReQoL data results provide us with more nuanced insights into the mental health challenges faced by our members. The ReQoL measure has proven to be a powerful tool for uncovering hidden struggles and tracking clinical progress. Utilizing the ReQoL in our clinical programs has significantly improved the effectiveness of our tech-enabled personalized interventions.”
About Ontrak Health
Ontrak Health (Nasdaq: OTRK) is a leading AI and technology-enabled behavioral healthcare company whose mission is to help improve the health and save the lives of as many people as possible. Ontrak identifies, engages, activates, and provides care pathways to treatment for the most vulnerable members of the behavioral health population who would otherwise fall through the cracks of the healthcare system. We engage individuals with anxiety, depression, substance use disorder, and chronic disease through personalized care coaching and customized care pathways that help them receive the treatment and advocacy they need, despite the socioeconomic, medical, and health system barriers that exacerbate the severity of their comorbid illnesses. The company's integrated intervention platform uses AI, predictive analytics, and digital interfaces combined with dozens of care coach engagements to deliver improved member health, better healthcare system utilization, and durable outcomes and savings to healthcare payors.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240912747147/en/
Company Contact:
Brandon LaVerne
Chief Executive Officer
blaverne@ontrakhealth.com
Investor Relations:
Ryan Halsted
Gilmartin Group
investors@ontrakhealth.com
Source: Ontrak, Inc.
FAQ
What is the ReQoL measure implemented by Ontrak Health (OTRK)?
How many Ontrak Health (OTRK) members showed improved ReQoL scores?
What percentage of Ontrak Health (OTRK) members reported poor quality of life at baseline?
How does Ontrak Health (OTRK) use the ReQoL data in its clinical programs?
